Survival in patients with surgically treated brain metastases: does infratentorial location matter?
Infra- versus supratentorial BM location
Surgery for brain metastasis
Survival
Journal
Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181
Informations de publication
Date de publication:
30 Mar 2023
30 Mar 2023
Historique:
received:
15
01
2023
accepted:
26
03
2023
revised:
09
03
2023
medline:
3
4
2023
entrez:
30
3
2023
pubmed:
31
3
2023
Statut:
epublish
Résumé
Surgical resection is a common treatment modality for brain metastasis (BM). Location of the BM might significantly impact patient survival and therefore might be considered in clinical decision making and patient counseling. In the present study, the authors analyzed infra- and supratentorial BM location for a potential prognostic difference. Between 2013 and 2019, 245 patients with solitary BM received BM resection at the authors' neuro-oncological center. In order to produce a covariate balance for commonly-known prognostic variables (tumor entity, age, preoperative Karnofsky Performance Score, and preoperative Charlson Comorbidity Index), a propensity score matching at a ratio of 1:1 between the cohort of patients with infra- and supratentorial BM location was performed using R. Overall survival (OS) rates were assessed for both matched cohorts of patients with BM. Sixty-one of 245 patients (25%) with solitary BM exhibited an infratentorial tumor location; 184 patients (75%) suffered from supratentorial solitary BM. Patients with infratentorial BM revealed a median OS of 11 months (95% confidence interval (CI) 7.4-14.6 months). Compared with this, median OS for the group of 61 individually matched patients with solitary supratentorial solitary BM was 13 months (95% CI 10.9-15.1 months) (p = 0.32). The present study suggests that the prognostic value of infra- and supratentorial BMs does not significantly differ in patients that undergo surgery for solitary BM. These results might encourage physicians to induce surgical therapy of supra- and infratentorial BM in a similar manner.
Identifiants
pubmed: 36997703
doi: 10.1007/s10143-023-01986-6
pii: 10.1007/s10143-023-01986-6
pmc: PMC10063486
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
80Informations de copyright
© 2023. The Author(s).
Références
J Radiosurg SBRT. 2016;4(2):89-96
pubmed: 29296433
Nat Rev Dis Primers. 2019 Jan 17;5(1):5
pubmed: 30655533
Nat Rev Clin Oncol. 2020 May;17(5):279-299
pubmed: 32080373
Front Oncol. 2021 Jul 26;11:713965
pubmed: 34381733
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):280-288
pubmed: 27478166
Neurol Res. 2014 Jan;36(1):13-25
pubmed: 24070068
J Neurooncol. 2020 Sep;149(3):455-461
pubmed: 32990861
Cancers (Basel). 2021 Mar 31;13(7):
pubmed: 33807384
Cancers (Basel). 2021 Jan 17;13(2):
pubmed: 33477374
Surg Neurol. 2009 Feb;71(2):184-7; discussion 187
pubmed: 18295837
Atherosclerosis. 1989 May;77(1):43-51
pubmed: 2719761
Front Oncol. 2021 Nov 02;11:772789
pubmed: 34796118
Nat Rev Cancer. 2020 Jan;20(1):4-11
pubmed: 31780784
Radiother Oncol. 2015 Nov;117(2):315-21
pubmed: 26347495
J Neurooncol. 2021 Jul;153(3):479-485
pubmed: 34115248
Neurooncol Adv. 2019 Sep 13;1(1):vdz017
pubmed: 32642653
Cancers (Basel). 2020 Oct 31;12(11):
pubmed: 33142701
Front Oncol. 2022 Jul 27;12:867462
pubmed: 35965535
J Clin Oncol. 2020 Nov 10;38(32):3773-3784
pubmed: 32931399
Rep Pract Oncol Radiother. 2021 Aug 12;26(4):512-517
pubmed: 34434566
Cancers (Basel). 2022 Mar 16;14(6):
pubmed: 35326666
J Clin Oncol. 2004 Jul 15;22(14):2865-72
pubmed: 15254054
Eur J Cancer. 1992;28A(8-9):1328-30
pubmed: 1515244